首页> Frontiers in oncology> Risk Factors for Biochemical Recurrence After PSMA-PET-Guided Definitive Radiotherapy in Patients With <i>De Novo</i> Lymph Node-Positive Prostate Cancer.

Risk Factors for Biochemical Recurrence After PSMA-PET-Guided Definitive Radiotherapy in Patients With <i>De Novo</i> Lymph Node-Positive Prostate Cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Simon K B,Spohn

第一单位： Department of Radiation Oncology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.;German Cancer Consortium (DKTK), Partner Site Freiburg, German Cancer Research Center (DKFZ), Freiburg, Germany.;Berta-Ottenstein-Programme, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

作者： Simon K B,Spohn ^[1] ; Viktoria,Birkenmaier ^[2] ; Juri,Ruf ^[3] ; Michael,Mix ^[3] ; August,Sigle ^[4] ; Erik,Haehl ^[5] ; Sonja,Adebahr ^[5] ; Tanja,Sprave ^[5] ; Eleni,Gkika ^[5] ; Alexander,Rühle ^[5] ; Nils H,Nicolay ^[5] ; Simon,Kirste ^[5] ; Anca L,Grosu ^[5] ; Constantinos,Zamboglou ^[6]

作者单位： Department of Radiation Oncology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.;German Cancer Consortium (DKTK), Partner Site Freiburg, German Cancer Research Center (DKFZ), Freiburg, Germany.;Berta-Ottenstein-Programme, Faculty of Medicine, University of Freiburg, Freiburg, Germany. ^[1] Department of Radiation Oncology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. ^[2] Department of Nuclear Medicine, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. ^[3] Department of Urology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. ^[4] Department of Radiation Oncology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.;German Cancer Consortium (DKTK), Partner Site Freiburg, German Cancer Research Center (DKFZ), Freiburg, Germany. ^[5] Department of Radiation Oncology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.;German Cancer Consortium (DKTK), Partner Site Freiburg, German Cancer Research Center (DKFZ), Freiburg, Germany.;Berta-Ottenstein-Programme, Faculty of Medicine, University of Freiburg, Freiburg, Germany.;German Oncology Center, European University Cyprus, Limassol, Cyprus. ^[6]

关键词 PSMA-PET/CT lymph node positive personalization prostate cancer radiotherapy risk factors

DOI 10.3389/fonc.2022.898774

PMID 35747822

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交